Medical medicine management system and method
By dividing drugs into multi-level management areas by time and calculating the management risk value of drugs, the problem that the existing drug management system cannot effectively manage the use quantity and storage status of drugs is solved, and dynamic identification and reminder of drug management is realized.
Patent Information
- Application Number
- CN202510009887.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-01-03
- Publication Date
- 2025-05-13
AI Technical Summary
The existing drug management system lacks linkage management based on drug time and the same type of drugs, and cannot effectively remind staff of the number of drugs used and storage status of drugs.
By dividing drugs into multi-level management areas by time, and calculating the storage time behavior value based on the quantity and storage time ratio of drugs in different regions, and combining the proportion of drugs in the first-level region, the management risk value of drugs is obtained, thereby achieving dynamic identification of the quantity of drugs used and storage status of drugs.
Through a multi-level management system, staff are effectively reminded to dynamically identify the amount of drugs used and storage status of drugs, improving the efficiency and accuracy of drug management.
Smart Images

Figure CN119993411A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of drug management, and in particular to a medical drug management system and method. Background Art
[0002] Pharmacy management realizes the management of pharmacy drug storage and in and out, drug inventory, drug price adjustment and other processes, including drug information acquisition, drug pricing, drug dispensing, account reconciliation, drug collection and other functions.
[0003] Drug warehouse management mainly realizes the management of the process from drug entry, storage to drug exit, drug inventory, drug price adjustment, etc. It also includes functions such as drug information acquisition, drug procurement plan, drug entry, drug exit, drug inventory, drug price adjustment, drug inventory management and drug expiration date management.
[0004] In the existing process, there is a lack of linkage management based on drug time and drugs of the same type. Based on this, the present application proposes a medical drug management system and method. Summary of the invention
[0005] The purpose of the present invention is to provide a medical drug management system and method, which divides drugs into a primary drug management area, a secondary drug management area and a tertiary drug management area according to time, and obtains a storage time behavior value of the drug according to the quantity of the same drug in different management areas and the drug storage ratio, and then processes the storage time behavior value and the proportion of the drug in the primary drug management area to obtain the management risk value of the drug in time and quantity, that is, through a multi-level management system, effectively reminding staff to dynamically identify the usage quantity and storage status of the drug.
[0006] The purpose of the present invention can be achieved through the following technical solutions:
[0007] A method for managing medical drugs, comprising the following steps:
[0008] Process the production time of the drug with the current time to obtain the drug storage time ratio;
[0009] The drug storage time ratio and the limit value of the drug storage time ratio threshold are processed to complete the regional division of the drugs;
[0010] Based on the regional division of drugs, drugs in different regions are integrated to obtain the storage time behavior value of the same drug;
[0011] Based on the storage time behavior value of drugs, drugs with the same or similar uses are processed to obtain the drug usage risk value, and the time and quantity of drugs are managed according to the drug usage risk value.
[0012] As a further solution of the present invention: the process of obtaining the drug storage time ratio is:
[0013] Calculate the difference between the production time of the drug and the current time to obtain the storage time of the drug;
[0014] The drug storage time ratio is calculated by calculating the ratio of the drug storage time to the drug effective time.
[0015] As a further solution of the present invention: the drug storage time ratio is recorded as Yi, and the limit values of the drug storage time ratio threshold are preset as Y1 and Y2;
[0016] When Yi<Y1, it means that the remaining time of drug expiration is short, and the corresponding drug is classified into the first-level drug management area;
[0017] When Y1≤Y i<Y2, it means that the remaining time of drug expiration is medium, and the corresponding drug is classified into the secondary drug management area;
[0018] When Yi≥Y2, it means that the remaining time before the drug expires is long, and the corresponding drug is classified into the third-level drug management area.
[0019] As a further solution of the present invention: obtaining the quantity of the same drug in the primary drug management area, the quantity of the same drug in the secondary drug management area, and the quantity of the same drug in the tertiary drug management area;
[0020] The ratio of the quantity of the same drug in the primary drug management area to the current total quantity of the drug is calculated to obtain the primary drug management area ratio;
[0021] The ratio of the quantity of the same drug in the secondary drug management area to the current total quantity of the drug is calculated to obtain the secondary drug management area ratio;
[0022] The ratio of the quantity of the same drug in the third-level drug management area to the current total quantity of the drug is calculated to obtain the third-level drug management area ratio.
[0023] As a further solution of the present invention: the first-level regional ratio of drug management is recorded as L1;
[0024] The secondary area ratio of drug management is recorded as L2;
[0025] The third-level regional ratio of drug management is recorded as L3;
[0026] That is, through the formula Calculate the storage time behavior value Li of the same drug;
[0027] in, It represents the sum of the drug storage time ratios of the same drug in the primary drug management area, Y1j represents the drug storage time ratio of a single drug in the primary drug management area, and j represents the quantity of the drug in the primary drug management area;
[0028] in, It represents the sum of the drug storage time ratios of the same drug in the secondary drug management area, Y2m represents the drug storage time ratio of a single drug in the secondary drug management area, and m represents the quantity of the drug in the secondary drug management area;
[0029] in, It represents the sum of the storage time ratios of the same drug located in the third-level drug management area. Y3n represents the storage time ratio of a single drug located in the third-level drug management area, and n represents the quantity of the drug in the third-level drug management area.
[0030] As a further solution of the present invention: obtaining the storage time behavior value of each independent drug in the drugs with the same or similar uses;
[0031] By formula The use risk value Ff of drugs with the same or similar uses is calculated, where r is the preset proportional coefficient.
[0032] As a further solution of the present invention: drugs with the same or similar uses are sorted according to the drug usage risk value Ff. The larger the drug usage risk value, the more drugs are about to expire, and the smaller the drug usage risk value, the fewer drugs are about to expire.
[0033] As a further solution of the present invention: a medical drug management system, comprising:
[0034] A drug identification module is used to process the production time of the drug and the current time to obtain the drug storage time ratio;
[0035] The drug area division module is used to process the drug storage time ratio and the limit value of the drug storage time ratio threshold to complete the regional division of drugs;
[0036] The drug storage status module integrates drugs in different regions based on the regional division of drugs to obtain the storage time behavior value of the same drug;
[0037] The drug management reminder module processes drugs of the same or similar use based on the storage time behavior value of the drugs, obtains the drug usage risk value, and completes the management of drug time and quantity based on the drug usage risk value.
[0038] Beneficial effects of the present invention: The present invention processes the production time of the drug with the current time to obtain the drug storage time ratio, processes the drug storage time ratio with the limit value of the drug storage time ratio threshold, divides the drugs into the first-level drug management area, the second-level drug management area and the third-level drug management area according to time, and obtains the storage time behavior value of the drug according to the quantity of the same drug in different management areas and the drug storage time ratio, and then processes the storage time behavior value with the proportion of the drug in the first-level drug management area to obtain the management risk value of the drug in time and quantity, that is, through a multi-level management system, the staff can be effectively reminded to dynamically identify the usage quantity and storage status of the drug. BRIEF DESCRIPTION OF THE DRAWINGS
[0039] The present invention will be further described below in conjunction with the accompanying drawings.
[0040] Figure 1 is a flow chart of a medical drug management method according to an embodiment of the present invention;
[0041] Figure 2 is a flowchart of a medical drug management system according to an embodiment of the present invention;
[0042] Figure 3 It is a schematic diagram of the structure of an electronic device according to an embodiment of the present invention. DETAILED DESCRIPTION
[0043] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0044] See also Figure 1 As shown, the present invention is a method for managing medical drugs, comprising the following steps:
[0045] Process the production time of the drug with the current time to obtain the drug storage time ratio;
[0046] The drug storage time ratio and the limit value of the drug storage time ratio threshold are processed to complete the regional division of the drugs;
[0047] Based on the regional division of drugs, drugs in different regions are integrated to obtain the storage time behavior value of the same drug;
[0048] Based on the storage time behavior value of drugs, drugs with the same or similar uses are processed to obtain the drug usage risk value, and the time and quantity of drugs are managed according to the drug usage risk value.
[0049] Calculate the difference between the production time of the drug and the current time to obtain the storage time of the drug;
[0050] Calculate the ratio of drug storage time to drug effective time to obtain drug storage time ratio;
[0051] Among them, the effective duration of the drug is the length of time from the drug’s effective date;
[0052] It should be noted that: the larger the drug storage time ratio is, the shorter the remaining time of drug expiration is;
[0053] Classify drugs by their expiration date based on the comparison of drugs during storage;
[0054] Specifically, the drug storage time ratio is recorded as Yi, and the limit values of the drug storage time ratio threshold are preset as Y1 and Y2;
[0055] Wherein, Y1 is the first limit value of the ratio threshold value during drug storage;
[0056] Y2 is the second limit value of the threshold value when the drug is stored, Y1<Y2;
[0057] When Yi<Y1, it means that the remaining time of drug expiration is short, and the corresponding drug is classified into the first-level drug management area;
[0058] When Y1≤Y i<Y2, it means that the remaining time of drug expiration is medium, and the corresponding drug is classified into the secondary drug management area;
[0059] When Yi≥Y2, it means that the remaining time before the drug expires is long, and the corresponding drug is classified into the third-level drug management area.
[0060] It should be noted that: the limit values Y1 and Y2 of the threshold value when the drug is stored are empirical values, which are determined by the staff based on experience;
[0061] In the actual process of obtaining, there are many groups of drug storage time ratios. The staff identifies the drug management level according to the drug storage time ratios of so many groups, thereby obtaining a corresponding relationship between the drug storage time ratio and the drug management level, and then derives and divides the drug storage time ratio threshold according to the drug management level status of the drug storage time ratio, thereby obtaining the limit values Y1 and Y2 of the drug storage time ratio threshold. By comparing the limit values of the drug storage time ratio threshold, the drug management level corresponding to the drug storage time ratio is identified;
[0062] Among them, the drug management warning level corresponding to the first-level drug management area is higher than the drug management warning level corresponding to the second-level drug management area, and the drug management warning level corresponding to the second-level drug management area is higher than the drug management warning level corresponding to the third-level drug management area.
[0063] Obtain the quantity of drugs in different levels of management areas;
[0064] Obtain the quantity of the same drug in the first-level drug management area, the quantity of the same drug in the second-level drug management area, and the quantity of the same drug in the third-level drug management area;
[0065] The quantity of the same drug in the first-level drug management area, the second-level drug management area, and the third-level drug management area is summed to obtain the current total quantity of the drug;
[0066] Calculate the ratio of the quantity of the same drug in the primary drug management area to the current total quantity of the drug to obtain the primary drug management area ratio, recorded as L1;
[0067] The ratio of the quantity of the same drug in the secondary drug management area to the current total quantity of the drug is calculated to obtain the secondary drug management area ratio, which is recorded as L2;
[0068] The ratio of the quantity of the same drug in the third-level drug management area to the current total quantity of the drug is calculated to obtain the third-level drug management area ratio, which is recorded as L3;
[0069] That is, through the formula Calculate the storage time behavior value of the same drug;
[0070] in, It represents the sum of the drug storage time ratios of the same drug in the primary drug management area, Y1j represents the drug storage time ratio of a single drug in the primary drug management area, and j represents the quantity of the drug in the primary drug management area;
[0071] in, It represents the sum of the drug storage time ratios of the same drug in the secondary drug management area, Y2m represents the drug storage time ratio of a single drug in the secondary drug management area, and m represents the quantity of the drug in the secondary drug management area;
[0072] in, It represents the sum of the storage time ratios of the same drug located in the third-level drug management area. Y3n represents the storage time ratio of a single drug located in the third-level drug management area, and n represents the quantity of the drug in the third-level drug management area.
[0073] Obtain the storage time behavior value of each independent drug in the drugs with the same or similar uses, sort each drug with the same or similar uses according to the storage time behavior value, and identify the use risk value of drugs with the same or similar uses. The specific process is as follows:
[0074] By formula Calculate the use risk value Ff of drugs with the same or similar uses, where r is the preset proportional coefficient;
[0075] The process of obtaining the preset proportional coefficient is as follows:
[0076] There are m groups of historical data, each group of historical data includes the ratio of the primary drug management area L1, the ratio of the sum of the drug storage time ratios of the same drug in the primary drug management area, and the use risk value Ff of drugs with the same and similar uses;
[0077] The m groups of historical data are fitted with a linear model, and the prepared historical data are brought into the selected fitting model for fitting to obtain the fitting coefficient, that is, the preset proportional coefficient.
[0078] Drugs with the same or similar uses are sorted according to the drug use risk value Ff. The larger the drug use risk value, the more drugs are about to expire, and the smaller the drug use risk value, the fewer drugs are about to expire.
[0079] Through the above arrangement, timely and effective early warning of the purchase volume or usage of drugs can be achieved.
[0080] Example 2
[0081] See also Figure 2 As shown, the present invention is a medical drug management system, comprising:
[0082] A drug identification module is used to process the production time of the drug and the current time to obtain the drug storage time ratio;
[0083] The drug area division module is used to process the drug storage time ratio and the limit value of the drug storage time ratio threshold to complete the regional division of drugs;
[0084] The drug storage status module integrates drugs in different regions based on the regional division of drugs to obtain the storage time behavior value of the same drug;
[0085] The drug management reminder module processes drugs of the same or similar use based on the storage time behavior value of the drugs, obtains the drug usage risk value, and completes the management of drug time and quantity based on the drug usage risk value.
[0086] Example 3
[0087] Reference Figure 3 The embodiment of the present invention further provides a computer device 3, comprising: a memory 302 and a processor 301 and a computer program 303 stored in the memory 302. When the computer program 303 is executed on the processor 301, a medical drug management method as described in any one of the above methods is implemented.
[0088] The computer device 3 may be a computing device such as a desktop computer, a notebook, a PDA, or a cloud server. The computer device 3 may include, but is not limited to, a processor 301 and a memory 302. Those skilled in the art will appreciate that
[0089] Figure 3 It is only an example of computer device 3 and does not constitute a limitation on computer device 3. It may include more or fewer components than shown in the figure, or a combination of certain components, or different components, for example, it may also include input and output devices, network access devices, etc.
[0090] The processor 301 may be a central processing unit (CPU), or other general-purpose processors, digital signal processors (DSP), application-specific integrated circuits (ASIC), field-programmable gate arrays (FPGA) or other programmable logic devices, discrete gate or transistor logic devices, discrete hardware components, etc. A general-purpose processor may be a microprocessor or any conventional processor, etc.
[0091] In some embodiments, the memory 302 may be an internal storage unit of the computer device 3, such as a hard disk or memory of the computer device 3. In other embodiments, the memory 302 may also be an external storage device of the computer device 3, such as a plug-in hard disk, a smart memory card (SmartMediaCard, SMC), a secure digital (Secure Digital, SD) card, a flash card (Flash Card), etc. equipped on the computer device 3. Further, the memory 302 may also include both an internal storage unit of the computer device 3 and an external storage device. The memory 302 is used to store an operating system, an application program, a boot loader (BootLoader), data, and other programs, such as the program code of the computer program. The memory 302 may also be used to temporarily store data that has been output or is to be output.
[0092] Example 4
[0093] An embodiment of the present invention further provides a computer-readable storage medium having a computer program stored thereon. When the computer program is executed by a processor, the medical drug management method as described in any one of the above methods is implemented.
[0094] In this embodiment, if the integrated unit is implemented in the form of a software functional unit and sold or used as an independent product, it can be stored in a computer-readable storage medium. Based on this understanding, the present application implements all or part of the processes in the above-mentioned embodiment method, which can be completed by instructing the relevant hardware through a computer program, and the computer program can be stored in a computer-readable storage medium. When the computer program is executed by the processor, the steps of the above-mentioned various method embodiments can be implemented. Among them, the computer program includes computer program code, and the computer program code can be in source code form, object code form, executable file or some intermediate form. The computer-readable medium can at least include: any entity or device that can carry the computer program code to the camera / terminal device, recording medium, computer memory, read-only memory (ROM, Read-Only Memory), random access memory (RAM, Random Access Memory), electric carrier signal, telecommunication signal and software distribution medium. For example, a USB flash drive, a mobile hard disk, a disk or an optical disk. In some jurisdictions, according to legislation and patent practice, computer-readable media cannot be electric carrier signals and telecommunication signals.
[0095] In the above embodiments, the description of each embodiment has its own emphasis. For parts that are not described or recorded in detail in a certain embodiment, reference can be made to the relevant descriptions of other embodiments.
[0096] The above is a detailed description of an embodiment of the present invention, but the content is only a preferred embodiment of the present invention and cannot be considered to limit the scope of implementation of the present invention. All equivalent changes and improvements made within the scope of the present invention should still fall within the scope of the patent coverage of the present invention.
Claims
1. A method for managing medical drugs, characterized in that: The following steps are involved: Process the production time of the drug with the current time to obtain the drug storage time ratio; The drug storage time ratio and the limit value of the drug storage time ratio threshold are processed to complete the regional division of the drugs; Based on the regional division of drugs, drugs in different regions are integrated to obtain the storage time behavior value of the same drug; Based on the storage time behavior value of drugs, drugs with the same or similar uses are processed to obtain the drug use risk value, and the time and quantity of drugs are managed according to the drug use risk value.
2. A medical drug management method according to claim 1, characterized in that: The process of obtaining the drug storage time ratio is as follows: Calculate the difference between the production time of the drug and the current time to obtain the storage time of the drug; The drug storage time ratio is calculated by calculating the ratio of the drug storage time to the drug effective time.
3. A medical drug management method according to claim 1, characterized in that: The drug storage time ratio is recorded as Yi, and the limit values of the drug storage time ratio threshold are preset as Y1 and Y2; When Yi<Y1, it means that the remaining time of drug expiration is short, and the corresponding drug is classified into the first-level drug management area; When Y1≤Yi<Y2, it means that the remaining time of drug expiration is medium, and the corresponding drug is classified into the secondary drug management area; When Yi≥Y2, it means that the remaining time before the drug expires is long, and the corresponding drug is classified into the third-level drug management area.
4. A medical drug management method according to claim 3, characterized in that: Obtain the quantity of the same drug in the first-level drug management area, the quantity of the same drug in the second-level drug management area, and the quantity of the same drug in the third-level drug management area; The ratio of the quantity of the same drug in the primary drug management area to the current total quantity of the drug is calculated to obtain the primary drug management area ratio; The ratio of the quantity of the same drug in the secondary drug management area to the current total quantity of the drug is calculated to obtain the secondary drug management area ratio; The ratio of the quantity of the same drug in the third-level drug management area to the current total quantity of the drug is calculated to obtain the third-level drug management area ratio.
5. A medical drug management method according to claim 4, characterized in that: The first-level regional ratio of drug management is recorded as L1; The secondary area ratio of drug management is recorded as L2; The third-level regional ratio of drug management is recorded as L3; That is, through the formula Calculate the storage time behavior value Li of the same drug; in, It represents the sum of the drug storage time ratios of the same drug in the primary drug management area, Y1j represents the drug storage time ratio of a single drug in the primary drug management area, and j represents the quantity of the drug in the primary drug management area; in, It represents the sum of the drug storage time ratios of the same drug in the secondary drug management area, Y2m represents the drug storage time ratio of a single drug in the secondary drug management area, and m represents the quantity of the drug in the secondary drug management area; in, It represents the sum of the storage time ratios of the same drug located in the third-level drug management area. Y3n represents the storage time ratio of a single drug located in the third-level drug management area, and n represents the quantity of the drug in the third-level drug management area.
6. A medical drug management method according to claim 5, characterized in that: Obtain the storage time behavior value of each independent drug within the same or similar use drugs; By formula The use risk value Ff of drugs with the same or similar uses is calculated, where r is the preset proportional coefficient.
7. A medical drug management method according to claim 6, characterized in that: Drugs with the same or similar uses are sorted according to their use risk value Ff. The larger the use risk value of a drug, the more drugs are about to expire, and the smaller the use risk value of a drug, the fewer drugs are about to expire.
8. A medical drug management system, characterized in that: include: A drug identification module is used to process the production time of the drug and the current time to obtain the drug storage time ratio; The drug area division module is used to process the drug storage time ratio and the limit value of the drug storage time ratio threshold to complete the regional division of drugs; The drug storage status module integrates drugs in different regions based on the regional division of drugs to obtain the storage time behavior value of the same drug; The drug management reminder module processes drugs of the same or similar use based on the storage time behavior value of the drugs, obtains the drug usage risk value, and completes the management of drug time and quantity based on the drug usage risk value.
Citation Information
Cited By
Electronic detonator full-cycle data management method and system
CN120746456A